Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.

Yu-Chien LeeJoshua K LinDarae KoSusan ChengElisabetta PatornoRobert J GlynnTheodore TsacogianisDae Hyun Kim

Published in: Journal of the American Geriatrics Society (2023)

Our results suggest an evidence-practice gap in the use of ARNI and GDMT in Medicare beneficiaries with HFrEF, particularly those with frailty. Efforts to narrow this gap are needed to reduce the burden of HFrEF in older adults.

Keyphrases

heart failure
community dwelling
quality improvement
primary care
physical activity
angiotensin ii
angiotensin converting enzyme
left ventricular
atrial fibrillation
binding protein
cardiac resynchronization therapy
affordable care act